Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

AI-generated NewsSnap summary based on source reporting.
Published: 2026-09-15
Category: business
Source: StreetInsider (via SEC 8-K filing)

Jazz Pharmaceuticals plc announced the completion of its acquisition of Actio Biosciences, Inc., making Actio a wholly-owned subsidiary. This acquisition is a material development in the company's growth strategy.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai